| For: | Labenz J, Malfertheiner P. Treatment of uncomplicated reflux disease. World J Gastroenterol 2005; 11(28): 4291-4299 [PMID: 16038023 DOI: 10.3748/wjg.v11.i28.4291] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i28/4291.htm |
| Number | Citing Articles |
| 1 |
Donald P. Kotler, Zheng Lin, Il J. Paik, Stanley Hsu. Principles of Diabetes Mellitus. 2017; doi: 10.1007/978-3-319-20797-1_27-2
|
| 2 |
Kunoor Jain-Spangler, Maryna Chumakova-Orin. Interventions for the Management of Post–Sleeve GERD. Digestive Disease Interventions 2021; 5(03) doi: 10.1055/s-0041-1730396
|
| 3 |
Lydie Izakovicova Holla, Petra Borilova Linhartova, Barbara Hrdlickova, Filip Marek, Jiri Dolina, Vladimir Rihak, Zdenek Kala. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett’s esophagus. Human Immunology 2013; 74(9) doi: 10.1016/j.humimm.2013.06.026
|
| 4 |
Stephanie Wong, Andrew Ruszkiewicz, Richard H Holloway, Nam Q Nguyen. Gastro-oesophageal reflux disease and eosinophilic oesophagitis: What is the relationship?. World Journal of Gastrointestinal Pathophysiology 2018; 9(3): 63-72 doi: 10.4291/wjgp.v9.i3.63
|
| 5 |
Naomi Uemura, Hideto Inokuchi, Hiroshi Serizawa, Toshiharu Chikama, Masao Yamauchi, Tomomi Tsuru, Toru Umezu, Toshiro Urata, Nobuo Yurino, Satoshi Tanabe, Tomoharu Yoshida, Susumu Kawamura, Atsushi Murakami, Munemitsu Yamamoto, Tsutomu Chiba. Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease. Journal of Gastroenterology 2008; 43(9) doi: 10.1007/s00535-008-2214-5
|
| 6 |
Tomomitsu Tahara, Tomoyuki Shibata, Masakatsu Nakamura, Joh Yonemura, Masaaki Okubo, Daisuke Yoshioka, Yoshio Kamiya, Tomiyasu Arisawa, Ichiro Hirata. Presence of Minimal Change Esophagitis Closely Correlates with Pathological Conditions in the Stomach. Digestive Diseases and Sciences 2012; 57(4) doi: 10.1007/s10620-011-1949-7
|
| 7 |
Meiling Yu, Jianghua Qian, Daohua Guo, Li Li, Xiaolin Liu. Severe adverse reactions caused by omeprazole: A case report. Experimental and Therapeutic Medicine 2016; 12(2) doi: 10.3892/etm.2016.3444
|
| 8 |
Lucía C. Fry, Klaus Mönkemüller, Peter Malfertheiner. Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions—A debate: Con. Current Treatment Options in Gastroenterology 2007; 10(4) doi: 10.1007/s11938-007-0073-4
|
| 9 |
Sashidhar Sagi, Marwan Ghabril. Perioperative Assessment of the Maxillofacial Surgery Patient. 2018; doi: 10.1007/978-3-319-58868-1_19
|
| 10 |
Jimmy M Bautista. The rising trend of on‐demand and intermittent proton pump inhibitor therapy in gastroesophageal reflux disease: What is the evidence?. Journal of Gastroenterology and Hepatology 2006; 21(s5) doi: 10.1111/j.1440-1746.2006.04713.x
|
| 11 |
K Furuta, K Adachi, S Ohara, T Morita, T Tanimura, K Koshino, Y Kinoshita. Relationship between the Acid-Inhibitory Effects of Two Proton Pump Inhibitors andCYP2C19Genotype in Japanese Subjects: A Randomized Two-Way Crossover Study. Journal of International Medical Research 2010; 38(4) doi: 10.1177/147323001003800430
|
| 12 |
Lucía C. Fry, Klaus Mönkemüller, Peter Malfertheiner. Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions—A debate: Con. Current GERD Reports 2007; 1(4) doi: 10.1007/s12171-007-0027-8
|
| 13 |
Asbjørn Mohr Drewes, Lars Arendt-Nielsen, Peter Funch-Jensen, Hans Gregersen. Experimental human pain models in gastro-esophageal reflux disease and unexplained chest pain. World Journal of Gastroenterology 2006; 12(18): 2806-2817 doi: 10.3748/wjg.v12.i18.2806
|
| 14 |
John W. Jacobs, Joel E. Richter. Diagnosis and Treatment of Gastroesophageal Reflux Disease. 2016; doi: 10.1007/978-3-319-19524-7_5
|
| 15 |
J. Labenz. Pathogenesis and Clinical Practice in Gastroenterology. 2008; doi: 10.1007/978-1-4020-8767-7_3
|
| 16 |
Charles Muller, Natalie Tapaskar, Robert T. Kavitt. Foregut Surgery. 2020; doi: 10.1007/978-3-030-27592-1_14
|
| 17 |
Robert N Lopez, Daniel A Lemberg. Gastro‐oesophageal reflux disease in infancy: a review based on international guidelines. Medical Journal of Australia 2020; 212(1) doi: 10.5694/mja2.50447
|
| 18 |
Elvan Isik, Serhat Bor. Comparison of the Efficacy of Dexrabeprazole and Rabeprazole in Inhibiting Intragastric and Intraesophageal Acidity in Gastroesophageal Reflux Disease. Journal of Clinical Gastroenterology 2026; doi: 10.1097/MCG.0000000000002449
|
| 19 |
Yue Zhou, Lina Xu, Haishaerjiang Wushouer, Aichen Yu, Ziyue Xu, Chaoyang Chen, Yimin Cui, Qinghong Lu, Xiaodong Guan, Luwen Shi. Acid Suppression Use Among Infants in One Tertiary Children's Hospital in China, 2015–2018: A Retrospective Observational Study. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.679203
|
| 20 |
Tala Mahmoud, Veeravich Jaruvongvanich, Rabih Ghazi, Rami Abusaleh, Barham K. Abu Dayyeh. Complete endoscopic removal of an eroded magnetic sphincter augmentation device. VideoGIE 2021; 6(10) doi: 10.1016/j.vgie.2021.05.023
|
| 21 |
Ekkehard Bayerdörffer, Marc-Andre Bigard, Werner Weiss, Fermín Mearin, Luis Rodrigo, Juan Enrique Dominguez Muñoz, Hennie Grundling, Tore Persson, Lars-Erik Svedberg, Nanna Keeling, Stefan Eklund. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0448-x
|
| 22 |
Daniel Skubleny, Noah J. Switzer, Jerry Dang, Richdeep S. Gill, Xinzhe Shi, Christopher de Gara, Daniel W. Birch, Clarence Wong, Matthew M. Hutter, Shahzeer Karmali. LINX® magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis. Surgical Endoscopy 2017; 31(8) doi: 10.1007/s00464-016-5370-3
|
| 23 |
I V Maev, D N Andreev, Yu A Kucheryavyy, R I Shaburov. Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection. Terapevticheskii arkhiv 2019; 91(8) doi: 10.26442/00403660.2019.08.000387
|
| 24 |
Donald P. Kotler, Zheng Lin, Il J. Paik. Principles of Diabetes Mellitus. 2015; doi: 10.1007/978-3-319-20797-1_27-1
|
| 25 |
Daniel A. Kroch, Ryan D. Madanick. Medical Treatment of Gastroesophageal Reflux Disease. World Journal of Surgery 2017; 41(7) doi: 10.1007/s00268-017-3954-2
|
| 26 |
Zdenek Kala, Jiří Dolina, Filip Marek, Lydie Izakovicova Holla. Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett’s esophagus. Journal of Human Genetics 2007; 52(6) doi: 10.1007/s10038-007-0148-z
|
| 27 |
Dan Carter, Ram Dickman. Practice styles, knowledge and attitudes of general practitioners and gastroenterology specialists who treat gastroesophageal reflux disease. Medicine 2018; 97(52) doi: 10.1097/MD.0000000000013781
|
| 28 |
IM Nu-Ri, Byoungjae Kim, Kwang-Yoon Jung, Tae Hoon Kim, Seung-Kuk Baek. Non-Surgical Animal Model of Gastroesophageal Reflux Disease by Overeating Induced in Mice. Journal of Investigative Medicine 2021; 69(6) doi: 10.1136/jim-2020-001691
|
| 29 |
H. Miwa, T. Yokoyama, K. Hori, T. Sakagami, T. Oshima, T. Tomita, Y. Fujiwara, H. Saita, T. Itou, H. Ogawa, Y. Nakamura, K. Kishi, Y. Murayama, E. Hayashi, K. Kobayashi, N. Tano, K. Matsushita, H. Kawamoto, Y. Sawada, A. Ohkawa, E. Arai, K. Nagao, N. Hamamoto, Y. Sugiyasu, K. Sugimoto, H. Hara, M. Tanimura, Y. Honda, K. Isozaki, S. Noda, S. Kubota, S. Himeno. Interobserver agreement in endoscopic evaluation of reflux esophagitis using a modified Los Angeles classification incorporating grades N and M: A validation study in a cohort of Japanese endoscopists. Diseases of the Esophagus 2008; 21(4) doi: 10.1111/j.1442-2050.2007.00788.x
|
| 30 |
Feng Li, Stephanie Denise Pointer, Jon P. Walker. The SAGES Manual of Foregut Surgery. 2019; doi: 10.1007/978-3-319-96122-4_11
|
| 31 |
Sudha Pandit, Moheb Boktor, Jonathan S. Alexander, Felix Becker, James Morris. Gastroesophageal reflux disease: A clinical overview for primary care physicians. Pathophysiology 2018; 25(1) doi: 10.1016/j.pathophys.2017.09.001
|
| 32 |
Christian Lottrup, Søren Schou Olesen, Asbjørn Mohr Drewes. The Pain System in Oesophageal Disorders: Mechanisms, Clinical Characteristics, and Treatment. Gastroenterology Research and Practice 2011; 2011 doi: 10.1155/2011/910420
|
| 33 |
Philip O Katz, Lauren B Gerson, Marcelo F Vela. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 2013; 108(3) doi: 10.1038/ajg.2012.444
|
| 34 |
Rachel Rosen, Yvan Vandenplas, Maartje Singendonk, Michael Cabana, Carlo DiLorenzo, Frederic Gottrand, Sandeep Gupta, Miranda Langendam, Annamaria Staiano, Nikhil Thapar, Neelesh Tipnis, Merit Tabbers. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines. Journal of Pediatric Gastroenterology and Nutrition 2018; 66(3) doi: 10.1097/MPG.0000000000001889
|
| 35 |
Alberto Aiolfi, Emanuele Asti, Daniele Bernardi, Gianluca Bonitta, Emanuele Rausa, Stefano Siboni, Luigi Bonavina. Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: Systematic review and meta-analysis. International Journal of Surgery 2018; 52 doi: 10.1016/j.ijsu.2018.02.041
|
| 36 |
Jinyuan Gan, Yarn Kit Chan, Deepa Chandra Segaran, Jean-Paul Kovalik, Alvin Eng, Phong Ching Lee, Jeremy Tan, Chin Hong Lim. Pepsin in saliva for the diagnosis of erosive esophagitis post-sleeve gastrectomy: a prospective observational study. Surgical Endoscopy 2023; 37(8) doi: 10.1007/s00464-023-10050-9
|
| 37 |
Lucía C. Fry, Klaus Mönkemüller, Peter Malfertheiner. Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions—A debate: Con. Current Treatment Options in Gastroenterology 2007; 10(4) doi: 10.1007/s11938-007-0073-4
|
| 38 |
Kumar Krishnan, John E. Pandolfino. Endoscopic therapies for gastroesophageal reflux disease. Techniques in Gastrointestinal Endoscopy 2014; 16(1) doi: 10.1016/j.tgie.2013.08.008
|
| 39 |
Ying Lian Xiao, Li Ya Zhou, Xiao Hua Hou, Yan Qing Li, Duo Wu Zou, Min Hu Chen. Chinese expert consensus on gastroesophageal reflux disease in 2020. Journal of Digestive Diseases 2021; 22(7) doi: 10.1111/1751-2980.13028
|
| 40 |
F. K. L. CHAN, Y. KINOSHITA. Review article: building an algorithm for the management of geriatric acid‐related disorders in Asia. Alimentary Pharmacology & Therapeutics Symposium Series 2007; 3(2) doi: 10.1111/j.1746-6342.2007.00078.x
|
| 41 |
Donald P. Kotler, Zheng Lin, Il J. Paik, Stanley Hsu. Principles of Diabetes Mellitus. 2017; doi: 10.1007/978-3-319-18741-9_27
|
| 42 |
Shengzhen Liu, Ningli Chai, Yaqi Zhai, Jiale Zou, Xiuxue Feng, Zhenjuan Li, Longsong Li, Xiaobin Zhang, Xiaoxiao Wang, Shasha Wang, En-Qiang Linghu. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)—a short-term study. Surgical Endoscopy 2020; 34(10) doi: 10.1007/s00464-019-07238-3
|
| 43 |
O Perigo, M Khan. The management of gastro-oesophageal reflux disease in the UK Armed Forces. Journal of The Royal Naval Medical Service 2017; 103(3) doi: 10.1136/jrnms-103-200
|
| 44 |
Mehtap Ozkahraman Kırık, Berna Uslu Coskun. Airway Diseases. 2023; doi: 10.1007/978-3-031-22483-6_133-1
|